Gut bacteria boost? new combo aims to improve liver cancer surgery outcomes
NCT ID NCT07306481
First seen Jan 04, 2026 · Last updated Apr 24, 2026 · Updated 16 times
Summary
This study tests whether taking a probiotic (Lactobacillus reuteri) before surgery, along with standard immunotherapy, helps people with liver cancer recover better and live longer. Forty adults with resectable liver cancer will be randomly assigned to receive either the probiotic plus immunotherapy or immunotherapy alone before their operation. Researchers will compare liver function recovery, complications, and survival between the two groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCC - HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.